Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 2,329 shares at $56.07 ($130K) on 2008-02-19, disclosed to the SEC on 2008-02-20.
Scheduled sale ($130k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.55 | 1,227 | $68K | 52.6% |
| 2 | $55.55 | 511 | $28K | 21.9% |
| 3 | $56.06 | 41 | $2K | 1.8% |
| 4 | $56.07 | 550 | $31K | 23.8% |
| Total | $55.68 avg | 2,329 | $130K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |